Business News Report Technology
September 06, 2023

Ibex Raises $55M in Series C to Advance AI-Driven Diagnostic Solutions

Ibex Raises $55M in Series C to Advance AI-Driven Diagnostic Solutions

Ibex Medical Analytics, an AI-powered medical diagnostics company, has secured $55 million in a Series C round led by 83North.

The round was joined by Sienna Venture Capital and existing investors in the company, Octopus Ventures, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital.

Since its inception in 2016, Ibex has raised a total of over $100 million. In 2021, the Israeli company raised $38 million in Series B funding.

Joseph Mossel, Co-Founder and CEO of Ibex, said that the company will use the funds to expand its footprint in the U.S. and grow its product portfolio to create more AI tools for pathologists.

Ibex offers AI-powered workflows and decision support tools for pathologists via its Galen platform. 

These tools include prostate, breast, and gastric cancer detection tools powered by AI. These include case prioritization worklist, slide viewer, IHC preordering, cancer heatmaps, grading, measurements, non-cancer findings, and AI-driven reporting.

Ibex said its artificial intelligence technology is built on Deep Learning algorithms trained by a team of pathologists, data scientists and software engineers. Per a Forbes report, the company claims that these algorithms replicate the functions of a pathologist and are capable of accurately detecting cancer in tissue biopsies.

In addition, Ibex’s AI diagnostic solutions are trained on data sourced from its partner, Maccabi Healthcare Services. The Israeli healthcare provider possesses one of the most extensive digitized clinical datasets globally, featuring millions of pathology slides and fully digitized pathology reports in its archives.

The company asserts that its Galen platform has been deployed in laboratories and pathology departments around the world. Last December, the company announced a live deployment of Galen Prostate by the University of Pittsburgh Medical Center (UPMC)

In January, Ibex collaborated with AstraZeneca and Daiichi Sankyo to develop an AI-powered biomarker-scoring product for breast cancer. Recently, the Betsi Cadwaladr University Health Board in Wales started piloting the use of Galen for breast cancer diagnosis.

“Our continued investment in Ibex is a testament to the company’s progress in recent years, bringing its unparalleled technology to laboratories, hospitals and digital pathology networks worldwide, catapulting the industry into an AI-powered era,” Gil Goren, Partner at 83North and Board Director of Ibex, said in a statement. “We are eager to see Ibex forge the way with new uses of AI in cancer diagnosis, supporting providers as they work to improve patient care and outcomes.”

Disclaimer

Any data, text, or other content on this page is provided as general market information and not as investment advice. Past performance is not necessarily an indicator of future results.


The Trust Project is a worldwide group of news organizations working to establish transparency standards.

Cindy is a journalist at Metaverse Post, covering topics related to web3, NFT, metaverse and AI, with a focus on interviews with Web3 industry players. She has spoken to over 30 C-level execs and counting, bringing their valuable insights to readers. Originally from Singapore, Cindy is now based in Tbilisi, Georgia. She holds a Bachelor's degree in Communications & Media Studies from the University of South Australia and has a decade of experience in journalism and writing.Get in touch with her via [email protected] with press pitches, announcements and interview opportunities.

More articles
Cindy Tan
Cindy Tan

Cindy is a journalist at Metaverse Post, covering topics related to web3, NFT, metaverse and AI, with a focus on interviews with Web3 industry players. She has spoken to over 30 C-level execs and counting, bringing their valuable insights to readers. Originally from Singapore, Cindy is now based in Tbilisi, Georgia. She holds a Bachelor's degree in Communications & Media Studies from the University of South Australia and has a decade of experience in journalism and writing.Get in touch with her via [email protected] with press pitches, announcements and interview opportunities.

Hot Stories
Join Our Newsletter.
Latest News

20 Most Underrated AI Startups in 2023: Ranked by Funding

AI remains a constant focal point for investors and entrepreneurs alike. While the spotlight often falls on ...

Know More

Ranked: Top 10 Countries by Estimated AI Contribution to Economy by 2030

AI stands at the cusp of a transformative era, poised to reshape virtually every sector and ignite ...

Know More
Join Our Innovative Tech Community

Read More

Read more
Justin Sun Announces 5,000 ETH Hack at HTX, Assures Full Coverage of Losses
Markets News Report
Justin Sun Announces 5,000 ETH Hack at HTX, Assures Full Coverage of Losses
September 25, 2023
Mitsubishi UFJ Trust Bank Partners with Binance Japan to Advance Stablecoin AdoptionĀ 
Markets News Report
Mitsubishi UFJ Trust Bank Partners with Binance Japan to Advance Stablecoin AdoptionĀ 
September 25, 2023
Mystiko.Network Unveils First Privacy Solution for L2 on Base Mainnet
News Report Technology
Mystiko.Network Unveils First Privacy Solution for L2 on Base Mainnet
September 25, 2023
OpenAI’s ChatGPT Unveils Major Upgrade, Adds Voice Conversation and Image Chat
News Report Technology
OpenAI’s ChatGPT Unveils Major Upgrade, Adds Voice Conversation and Image Chat
September 25, 2023
What You
Need to Know

Subscribe To Our Newsletter.
Daily search marketing tidbits for savvy pros.